Pivotal Trial to Evaluate the Safety and Efficacy of the Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions (ORBIT II)
Jeffrey W. Chambers, Robert L. Feldman, Stevan I. Himmelstein, Rohit Bhatheja, Augusto E. Villa, Neil E. Strickman, Richard A. Shlofmitz, Daniel D. Dulas, Dinesh Arab, Puneet K. Khanna, Arthur C. Lee, Magdi G.H. Ghali, Rakesh R. Shah, Thomas P. Davis, Christopher Y. Kim, Zaheed Tai, Kirit C. Patel, Joseph A. Puma, Prakash Makam, Barry D. Bertolet and Georges Y. Nseir
Cumulative MACE Rates
Values are %.
MACE = major adverse cardiac events; MI = myocardial infarction; TVR = target vessel revascularization.